GlassScriptPhysician profile
James Hale Adlam
NPI 1083688451
$5,524.62
in general payments reported to CMS, 2019-2025
20 companies · $1,360 in 2025
The $1,360 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.60 · 2021: $144 · 2022: $802 · 2023: $1,629 · 2024: $1,558 · 2025: $1,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,547.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,275.45 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Dragonfly Opstar, Diamondback Coronary |
| Shockwave Medical, INC | $1,076.12 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $685.05 | 2022-2025 | Synergy, General - Therapies, Watchman Access System |
| Biotronik INC. | $352.88 | 2022-2024 | Orsiro Mission, Pk Papyrus, Recross |
| Abiomed | $289.24 | 2023-2025 | Impella |
| Terumo Medical Corporation | $128.35 | 2024 | Tr Band |
| Edwards Lifesciences Corporation | $122.10 | 2023 | Sapien 3 Ultra Resilia |
| Philips North America LLC | $94.52 | 2022 | |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Novo Nordisk INC | $79.12 | 2024-2025 | Ozempic |
| Penumbra, INC. | $63.06 | 2023 | Indigo System |
| Novartis Pharmaceuticals Corporation | $49.47 | 2019-2025 | |
| Medtronic, INC. | $46.83 | 2023 | Onyx Frontier |
| Kestra Medical Technology Services, INC. | $46.32 | 2024 | Assure Wcd |
| Acist Medical Systems, INC. | $39.04 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $35.45 | 2025 | Wainua |
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.92 | 2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $12.20 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6.76 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Adlam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.